Flushed with the success of its COVID-19 vaccine, BioNTech has pressed the accelerator on the development of shots for other infectious diseases, and now plans to take malaria and tuberculosis ...

The development and implementation of a malaria vaccine would constitute a major breakthrough for global health. Recently, numerous new candidates have entered clinical testing, following ...

BioNTech, which produced the first MRNA ... other continents and ultimately be used to produce other MRNA vaccines - against malaria, for example. For now, he says, it's a necessity to bring ...

Each year malaria causes over 200 million disease episodes and 400,000 deaths, with an estimated two-thirds of those deaths being among children under the age of five. In a long-running effort ...

The first 846,000 doses of the R21 malaria vaccine arrived in Abuja, Nigeria, on Thursday, marking a milestone in efforts to eliminate malaria. According to the World Health Organization ...

However, production of the mRNA used in vaccines is hindered by its ... Oct. 23, 2024 — Maternal antibodies passed across the placenta can interfere with the response to the malaria vaccine ...

The federal government has received the first batch of 846,000 doses of the R21 malaria vaccine from Gavi, the Vaccine Alliance. Speaking during yesterday’s official launch of the vaccine in ...

The national campaign comes after a successful pilot phase in Kenya, Ghana and Malawi that saw a 13% drop in malaria deaths. Katie O'Brien is the World Health Organisation's vaccine direction ...

Maternal antibodies passed across the placenta can interfere with the response to the malaria vaccine, which would explain its lower efficacy in infants under five months of age, according to research ...

The malaria vaccine is expected to be delivered to Nigeria in Abuja by the WHO. Nigeria is set to receive its first consignment of the highly anticipated malaria vaccines on Thursday, marking a ...

including the Pfizer-BioNTech COVID-19 vaccine and BioNTech’s investigational malaria and tuberculosis vaccines. The Company exploits a wide array of computational discovery and therapeutic drug ...

Several observations point toward the possibility of a vaccine development strategy against the disease-associated blood stage form of the malaria parasite. Protection against clinical malaria ...